In urine samples from the cases with SRMs, significantly higher methylation levels and/or frequencies of TFAP2B, TAC1, PCDH8, ZNF677, and FLRT2 were detected in comparison to controls in support of our previous observations of the diagnostic potential of these DNA methylation biomarkers in RCC [22]. This evidence concerns the gene TAC1 and renal cell carcinoma.